Showing results (211-220 of 247) with videos related to
Sort By:
Pageof 25
Frontiers in Oncology|June 9, 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia ProgressionLin Xiao, Mawar Karsa, Emma Ronca, et al.British Journal of Haematology|December 23, 2025
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemiaDavid T Yeung, Andrew P Grigg, John Reynolds, et al.Blood Advances|September 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2010
Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanismsJane Oliaro, Vanessa Van Ham, Faruk Sacirbegovic, et al.Blood Advances|February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemiaHarinder Gill, Francesca Palandri, David M Ross, et al.Cell Reports|November 26, 2013
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsMichaela Waibel, Vanessa S Solomon, Deborah A Knight, et al.The Lancet. Haematology|July 22, 2024
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trialMatteo Giovanni Della Porta, Guillermo Garcia-Manero, Valeria Santini, et al.Blood Advances|April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 studyHarinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.Cancer Discovery|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell MemoryEmily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.Cell Death and Differentiation|July 13, 2022
Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysisIsabella Y Kong, Stephanie Trezise, Amanda Light, et al.Pageof 25